![Finger 1.jpg](https://static.wixstatic.com/media/3acb1f_dd9daeb8b8c743b2ab6a37e658849578~mv2.jpg/v1/fill/w_980,h_468,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/3acb1f_dd9daeb8b8c743b2ab6a37e658849578~mv2.jpg)
Quick Study.
Let’s get right to the point.
No one has time to wait for answers. That’s why we developed QScout™ RLD (Rapid Leukocyte Differential). It reports a white blood cell and differential count at patient-side in about 2 minutes from a drop of blood.* Results include immature infection-fighting cells some labs count manually.
News that counts.
AAD awarded BARDA contract to develop next gen CBC, sepsis diagnostic system
​
​AAD, developer of rapid diagnostic and data systems, today announced that it has been awarded a federal contract of $5 million with potential to award up to $12.6 million for the development of an improved diagnostic system designed to deliver faster complete blood count (CBC) test results and the earlier detection of severe infection, including sepsis.
​
![Qscout RLDtm Logo.png](https://static.wixstatic.com/media/3acb1f_2dfeedaceaf84b1e88fdfd4c581aefb1~mv2.png/v1/fill/w_281,h_96,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Qscout%20RLDtm%20Logo.png)
Forget the hassle.
QScout™ RLD requires no lengthy machine startup time or sample prep. No wet reagents that need to be changed or disposed. No pumps. Only a drop of blood. It goes from powered off to your first result in about 3 minutes.It’s easy to use with minimal training.
![QscoutRLD.png](https://static.wixstatic.com/media/3acb1f_ccd7c1c1dc774ba6b51478a532524a39~mv2.png/v1/fill/w_258,h_292,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/QscoutRLD.png)
See the difference.
It’s an imaging-based system not prone to the challenges of flow cytometry or the Coulter Principle. Cells are examined directly by a trained computer using AI instead of indirect measures like light scatter or electrical resistance.
If you’re an investigator interested in clinical trials, please contact us.
​
​